Y. Maung Maung Myint (Stevenage, United Kingdom), M. Lipman (London, United Kingdom)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Morphological features of non-tuberculous mycobacteriosis in patients operated on for lung tuberculosis
L. Lepeha (Moscow, Russian Federation), V. Aliev (Moscow, Russian Federation), L. Chernousova (Moscow, Russian Federation), E. Krasnikova (Moscow, Russian Federation), N. Makaryants (Moscow, Russian Federation), M. Bagirov (Moscow, Russian Federation)
|   |
Adverse reactions in the treatment of patients with non-tuberculous pulmonary mycobacteriosis.
E. Vladimirova (??????, Russian Federation), S. Evgeny (??????, Russian Federation), Z. Anna (??????, Russian Federation), D. Svetlana (??????, Russian Federation)
| |
Interferon gamma (IFN?) pathway deficiency and severe NTM disease
S. Sharma (Woking Surrey, United Kingdom), F. Ali (Woking Surrey, United Kingdom), S. Sujoy (Woking Surrey, United Kingdom), K. Jola (Woking Surrey, United Kingdom)
| |
Bedaquiline in the treatment of multi-drug resistant non-tuberculous mycobacteria soft tissue infections: a case series
F. Wright (Torquay, United Kingdom), L. Anning (Torquay, United Kingdom), B. Hulance (Torquay, United Kingdom)
| |
Immune profiling to differentiate progressive from non-progressive non-tuberculous mycobacteria lung disease: A pilot study
P. Marty (Rochester, United States of America), P. Escalante (Rochester, United States of America), V. Van Keulen (Rochester, United States of America), C. Erskine (Rochester, United States of America), M. Shah (Rochester, United States of America), K. Pennington (Rochester, United States of America), T. Peikert (Rochester, United States of America)
| |
T cells subtypes in pleural effusion of tuberculous and non-tuberculous patients
N. Dalil Roofchayee (Tehran, Islamic Republic of Iran), M. Marjani (Tehran, Islamic Republic of Iran), N. K.Dezfuli (Tehran, Islamic Republic of Iran), E. Mortaz (Tehran, Islamic Republic of Iran)
| |
Posttreatment Lymphopenia Is Associated With an Increased Risk of Redeveloping Nontuberculous Mycobacterial Lung Disease in Patients With Mycobacterium avium Complex Lung Disease
K. Furuuchi (Kiyose, Tokyo, Japan), K. Fujiwara (Kiyose, Tokyo, Japan), F. Uesugi (Kiyose, Tokyo, Japan), M. Shimoda (Kiyose, Tokyo, Japan), Y. Tanaka (Kiyose, Tokyo, Japan), T. Yoshiyama (Kiyose, Tokyo, Japan), K. Yoshimori (Kiyose, Tokyo, Japan), A. Kurashima (Kiyose, Tokyo, Japan), K. Ohta (Kiyose, Tokyo, Japan), K. Morimoto (Kiyose, Tokyo, Japan)
| |
Sputum proteomics of CF, BE and COPD with or without NTM infections
R. Hull (Sheffield, United Kingdom), J. Huang (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), H. Ellis (London, United Kingdom), B. Cookson (London, United Kingdom), M. Moffatt (London, United Kingdom), M. Loebinger (London, United Kingdom), J. Chalmers (Dundee, United Kingdom)
| |
The non-tuberculous pulmonary disease experience in a general respiratory clinic in the UK
Y. Maung Maung Myint (Watford, United Kingdom), S. Ananth (Watford, United Kingdom), C. Stavropolous (Watford, United Kingdom), J. Anitha (Watford, United Kingdom), M. Vidwans (Watford, United Kingdom), P. Nandasiri (Watford, United Kingdom), A. Jayaratnam (Watford, United Kingdom)
| |
PREVALENCE OF NON TUBERCULOUS MYCOBACTERIA (NTM) IN HIGH RISK COPD PATIENTS
B. Gonzalez Quero (Barakaldo, Spain), E. Tabernero Huguet (Barakaldo, Spain), P. Sobradillo Ecenarro (Barakaldo, Spain), E. Garay Llorente (Barakaldo, Spain), J. Andia Iturrate (Barakaldo, Spain), L. Garcia Echebarria (Barakaldo, Spain), M. Iriberri Pascual (Barakaldo, Spain)
| |
Nontuberculous mycobacteria in respiratory tract samples: what does-it mean?
S. Essebaa (Ariana, Tunisia), H. Daghfous (Ariana, Tunisia), A. Ben Mansour (Ariana, Tunisia), S. Ben Saad (Ariana, Tunisia), S. Fenniche (Ariana, Tunisia), N. Chaouch (Ariana, Tunisia), L. Gharbi (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia), H. Ghedira (Ariana, Tunisia), L. Megdiche (Ariana, Tunisia), L. Slim (Ariana, Tunisia), F. Tritar (Ariana, Tunisia)
| |
Nontuberculous pulmonary mycobacteriosis caused by slowly growing nontuberculous mycobacteria as pulmonary comorbidity
A. Sargsyan (Moscow, Russian Federation), N. Makaryants (Moscow, Russian Federation), L. Lepekha (Moscow, Russian Federation), A. Zaitseva (Moscow, Russian Federation)
| |
Late Breaking Abstract - The use of Xpert Ultra in the diagnosis of tuberculosis in childhood and adolescence
A. Amaral Ibiapina Parente (Rio De Janeiro (RJ), Brazil), R. Baroni Aurílio (Rio De Janeiro (RJ), Brazil), C. Couto Sant'Anna (Rio De Janeiro (RJ), Brazil), M. Bazhuni Pombo Sant'Anna (Rio De Janeiro (RJ), Brazil), A. Lineu Kriski (Rio De Janeiro (RJ), Brazil), T. Da Silva Santos Malaquias (Rio De Janeiro (RJ), Brazil), S. Ferreira (Rio De Janeiro (RJ), Brazil), C. Pereira (Rio De Janeiro (RJ), Brazil), L. De Melo Lima (Rio De Janeiro (RJ), Brazil), M. Alexandrino De Souza Pinheiro (Rio De Janeiro (RJ), Brazil), B. Marques Barreto (Rio De Janeiro (RJ), Brazil)
| |